EP Patent

EP3873443A1 — Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof

Assigned to Peloton Therapeutics Inc · Expires 2021-09-08 · 5y expired

What this patent protects

Provided herein are solid dispersions comprising a HIF-2α inhibitor, pharmaceutical compositions comprising the solid dispersions, and methods for treating HIF-2α-mediated diseases and conditions.

USPTO Abstract

Provided herein are solid dispersions comprising a HIF-2α inhibitor, pharmaceutical compositions comprising the solid dispersions, and methods for treating HIF-2α-mediated diseases and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP3873443A1
Jurisdiction
EP
Classification
—
Expires
2021-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Peloton Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.